Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

30.0%

3 terminated/withdrawn out of 10 trials

Success Rate

70.0%

-16.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(50.0%)
Phase 1
3(37.5%)
Phase 2
1(12.5%)
8Total
N/A(4)
Phase 1(3)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)